These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 23340125

  • 1. The Athens TAVR Registry of newer generation transfemoral aortic valves: 30-day outcomes.
    Spargias K, Toutouzas K, Chrissoheris M, Synetos A, Halapas A, Paizis I, Latsios G, Stathogiannis K, Papametzelopoulos S, Zanos S, Pavlides G, Zacharoulis A, Antoniades A, Stefanadis C.
    Hellenic J Cardiol; 2013; 54(1):18-24. PubMed ID: 23340125
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W, Grossmann B, Geisler T, Steeg M, Droppa M, Jorbenadze R, Haap M, Gawaz M, Fateh-Moghadam S.
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [Abstract] [Full Text] [Related]

  • 3. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E, Borz B, Godin M, Tron C, Litzler PY, Bessou JP, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher JN, Bauer F, Cribier A, Eltchaninoff H.
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [Abstract] [Full Text] [Related]

  • 4. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF, Kodali S, Doshi D, Fischbein MP, Yeung AC, Tuzcu EM, Rihal CS, Babaliaros V, Zajarias A, Herrmann HC, Brown DL, Mack M, Teirstein PS, Whisenant BK, Makkar R, Kapadia S, Leon MB, PARTNER Trial Investigators.
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM, Shivaraju A, Schneider S, Krapf S, Oertel F, Burgdorf C, Ott I, Sumer C, Kastrati A, von Scheidt W, Thilo C.
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [Abstract] [Full Text] [Related]

  • 8. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M, Rodés-Cabau J, Urena M, DeLarochelliere R, Dumont E, Masson JB, Willson AB, Binder RK, Toggweiler S, Leipsic J, Wood DA, Webb JG.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):664-70. PubMed ID: 22744829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
    Linke A, Woitek F, Merx MW, Schiefer C, Möbius-Winkler S, Holzhey D, Rastan A, Ender J, Walther T, Kelm M, Mohr FW, Schuler G.
    Circ Cardiovasc Interv; 2012 Oct 01; 5(5):689-97. PubMed ID: 23048050
    [Abstract] [Full Text] [Related]

  • 11. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A.
    JACC Cardiovasc Interv; 2015 Apr 27; 8(5):657-69. PubMed ID: 25946437
    [Abstract] [Full Text] [Related]

  • 12. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
    Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G, CHOICE investigators.
    JAMA; 2014 Apr 16; 311(15):1503-14. PubMed ID: 24682026
    [Abstract] [Full Text] [Related]

  • 13. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C, Bisleri G, Moggi A, Di Bacco L, Tespili M, Repossini A, Rambaldini M.
    Interact Cardiovasc Thorac Surg; 2015 Jan 16; 20(1):90-5. PubMed ID: 25320140
    [Abstract] [Full Text] [Related]

  • 14. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, Abizaid AAC, Ramos AIO, Arrais M, Le Bihan DCS, Barretto RBM, Moreira AC, Sousa AGMR, Eduardo Sousa J.
    Catheter Cardiovasc Interv; 2017 Jul 16; 90(1):139-146. PubMed ID: 28029207
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M, Webb JG, Tamburino C, Van Mieghem NM, Makkar RR, Piazza N, Latib A, Sinning JM, Won-Keun K, Bleiziffer S, Bedogni F, Kapadia S, Tchetche D, Rodés-Cabau J, Fiorina C, Nombela-Franco L, De Marco F, de Jaegere PP, Chakravarty T, Vaquerizo B, Colombo A, Svensson L, Lange R, Nickenig G, Möllmann H, Walther T, Della Rosa F, Elhmidi Y, Dvir D, Brambilla N, Immè S, Sgroi C, Gulino S, Todaro D, Pilato G, Petronio AS, Tamburino C.
    Circ Cardiovasc Interv; 2016 Sep 16; 9(9):. PubMed ID: 27578840
    [Abstract] [Full Text] [Related]

  • 16. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A.
    JACC Cardiovasc Interv; 2010 Nov 16; 3(11):1110-21. PubMed ID: 21087745
    [Abstract] [Full Text] [Related]

  • 17. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L, Nissen H, Nielsen NE, Rück A, Busund R, Klaarborg KE, Soendergaard L, Harnek J, Miettinen H, Eskola M, Wahba A, Laine M.
    J Thorac Cardiovasc Surg; 2013 Nov 16; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [Abstract] [Full Text] [Related]

  • 18. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.
    J Am Coll Cardiol; 2014 Mar 25; 63(11):1100-9. PubMed ID: 24291283
    [Abstract] [Full Text] [Related]

  • 19. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
    Kaya D, Tanriverdi Z, Dursun H, Colluoglu T.
    Int J Cardiovasc Imaging; 2016 Sep 25; 32(9):1371-1378. PubMed ID: 27278270
    [Abstract] [Full Text] [Related]

  • 20. Transcatheter Aortic Valve Replacement Using Transaortic Access: Experience From the Multicenter, Multinational, Prospective ROUTE Registry.
    Bapat V, Frank D, Cocchieri R, Jagielak D, Bonaros N, Aiello M, Lapeze J, Laine M, Chocron S, Muir D, Eichinger W, Thielmann M, Labrousse L, Rein KA, Verhoye JP, Gerosa G, Baumbach H, Bramlage P, Deutsch C, Thoenes M, Romano M.
    JACC Cardiovasc Interv; 2016 Sep 12; 9(17):1815-22. PubMed ID: 27609256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.